About Semaglutide
Semaglutide is a synthetic GLP-1 receptor agonist used in metabolic and endocrine research. Supplied as a lyophilized powder for laboratory investigations of incretin receptor pharmacology, glucose-regulatory signaling, and downstream pathway activity in controlled experimental systems. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99(HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations.
Recent research on Semaglutide: Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations.
Read Full Study on PubMedMetabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and Rat Plasma.
Recent research on Semaglutide: Metabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and Rat Plasma.
Read Full Study on PubMedAdditional Studies
Correction.
Recent research on Semaglutide: Correction.
Read on PubMedSemaglutide attenuates diabetic vascular calcification by enhancing autophagy and lysosomal function via targeting CPNE1.
Recent research on Semaglutide: Semaglutide attenuates diabetic vascular calcification by enhancing autophagy and lysosomal function via targeting CPNE1.
Read on PubMedComplementary neuroprotective effects of semaglutide and papaya in diabetic encephalopathy via antioxidant and insulin-signaling pathways.
Recent research on Semaglutide: Complementary neuroprotective effects of semaglutide and papaya in diabetic encephalopathy via antioxidant and insulin-signaling pathways.
Read on PubMedImmune-mediated necrotising myopathy following semaglutide treatment: a contributing factor?
Recent research on Semaglutide: Immune-mediated necrotising myopathy following semaglutide treatment: a contributing factor?
Read on PubMedThe Effect of GLP-1 Receptor Agonists on Alanine Aminotransferase and Other Metabolic Parameters in Youths with Obesity: A Systematic Review and Meta-Analysis.
Recent research on Semaglutide: The Effect of GLP-1 Receptor Agonists on Alanine Aminotransferase and Other Metabolic Parameters in Youths with Obesity: A Systematic Review and Meta-Analysis.
Read on PubMedNew weight loss pill outperforms oral semaglutide for diabetes patients, study reports.
Recent research on Semaglutide: New weight loss pill outperforms oral semaglutide for diabetes patients, study reports.
Read on PubMedRelated Research
Purchase Semaglutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.